Acquired factor V inhibitor: A case report

Acta Clinica Croatica

Volumn 45, Issue 3, 2006, Pages 199-201

  Gaćina, Petar ^a   Kušec, Rajko ^b   Čaržavec, Dubravka ^a   Raić, Biserka ^a   Stančić, Vladimir ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Antibodies immunology; Blood coagulation disorders immunology; Blood coagulation factors antagonists and inhibitors; Case report; Factor V adverse effects; Factor V immunology

Indexed keywords

ANTIBIOTIC AGENT; FIBRIN GLUE; PROTEIN INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE REPORT; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; MEDICAL ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SCREENING;

EID: 33751539272     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. KATZMANN JA, NESHEIM ME, HIBBARD LS, MANN KG. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 1981;78:162-6.
2. NESHEIM ME, KATZMANN JA, TRACY PB, MANN KG. Factor V. Methods Enzymol 1981;80:249-74.
3. TRACY PB, EIDE LL, BOWIE EJ, MANN KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982;60:59-63.
4. GEORGE S, NAGABHUSHANA MS, CYRAN EM. Coagulopathy due to an acquired factor V inhibitor and subsequent thrombosis. Am J Hematol 1995;49:98-100.
5. KAPUR A, KELSEY PR, ISAACS PE. Factor V inhibitor in thrombosis. Am J Hematol 1993;42:384-8.
6. nd edition. Princeton, NJ: Medica; 1995, pp. 9-24.
7. STREIFF MB, NESS PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002;42:18-26.
8. KNÖBL P, LECHNER K. Acquired factor V inhibitors. Baillieres Clin Haematol 1998;11:305-18
9. ORTEL TL, CHARLES LA, KELLER FG, MAREOM PK, OLDHAM HN Jr, KANE WH et al. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis. Am J Hematol 1994;45:128-35.
10. LUCIA JF, AGUILAR C. A case of an asymptomatic idiopathic inhibitor to coagulation factor V. Haemophilia 2005;11:178-80.
11. ALVING BM, WEINSTEIN MJ, FINLAYSON JS, MENITOVE JE, FRATANTONI JC. Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 1995;35:783-90.
12. NESHEIM ME, NICHOLS WL, COLE TL, HOUSTON JG, SCHENK RB, MANN KG et al. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986;77:405-15.
13. FLAHERTY MJ, HENDERSON R, WENER MH. Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med 1989;111:631-4.
14. RAMAN B, BATCHEV C, SHURAFA M. Acquired factor V inhibitors showing positive platelet neutralization test and responding to platelet transfusions: report of four cases (abstract). Thromb Haemost 1995;73:1426.
15. MCGLASSON D, MERCIER R, POTEMPA L, PATTERSON W. Platelet neutralization procedure: atypical results seen with factor V deficiency with and without an inhibitor. Clin Lab Sci 1990;3:119-21.
16. BUCLIN T, SCHMIDT PM, HAUERT J, WINKEL L, CHAPUIS G, BACHMANN F et al. Acquired factor V inhibitor treated with intravenous immunoglobulins. Schweiz Med Wochenschr 1992;122:1968-70.
17. TARANTINO MD, ROSS MP, DANIELS TM, NICHOLS WL. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. J Pediatr Hematol Oncol 1997;19:226-31.
18. TRIBL B, KNÖBL P, DERFLER K, KAPIOTIS S, ASPOCK G, JAGER U et al. Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. Ann Hematol 1995;71:199-203.
19. FU YX, KAUFMAN R, RUDOLPH AE, COLLUM SE, BLINDER MA et al. Multimodality therapy of an acquired factor V inhibitor. Am J Hematol 1996;51:315-8.
20. GRACE C, WOLF P. Proceedings: A high titre circulating inhibitor of human factor V: clinical, biochemical and immunological features and its treatment by plasmapheresis. Thromb Diath Haemorrh 1975;34:322.
21. ONUORA CA, LINDENBAUM J, NOSSEL HL. Massive hemorrhage associated with circulating antibodies to factor V. Am J Med Sci 1973;265:407-17.
22. CHEDIAK J, ASHENHURST JB, GARLICK I, DESSER RK. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood 1980;56:835-41.